Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (281-290 of 453) with videos related to

Pageof 46
Sort By:
Oncotarget|May 10, 2014
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytesKonrad Gabrusiewicz, Dan Liu, Nahir Cortes-Santiago, et al.
Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Cancers|January 16, 2020
Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against GlioblastomaJing Cui, Herui Wang, Rogelio Medina, et al.
International Journal of Radiation Oncology, Biology, Physics|February 26, 2013
Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastomaAaron P Brown, Christian L Barney, David R Grosshans, et al.
Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2015
Genetic Modulation of Neurocognitive Function in Glioma PatientsYanhong Liu, Renke Zhou, Erik P Sulman, et al.
Advanced Therapeutics|March 12, 2021
Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA)Rogelio Medina, Herui Wang, Veronika Caisová, et al.
Neuro-Oncology|December 15, 2015
MiR-138 exerts anti-glioma efficacy by targeting immune checkpointsJun Wei, Edjah K Nduom, Ling-Yuan Kong, et al.
Neuro-Oncology Advances|March 5, 2025
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History StudyKaitlynn Slattery, McKenzie C Kauss, Dhaivat Raval, et al.
The Oncologist|February 17, 2021
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable ChordomaPeter Joseph DeMaria, Marijo Bilusic, Deric M Park, et al.
Pageof 46

Showing results (281-290 of 453) with videos related to

Sort By:
Pageof 46
Oncotarget|May 10, 2014
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytesKonrad Gabrusiewicz, Dan Liu, Nahir Cortes-Santiago, et al.
Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Cancers|January 16, 2020
Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against GlioblastomaJing Cui, Herui Wang, Rogelio Medina, et al.
International Journal of Radiation Oncology, Biology, Physics|February 26, 2013
Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastomaAaron P Brown, Christian L Barney, David R Grosshans, et al.
Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2015
Genetic Modulation of Neurocognitive Function in Glioma PatientsYanhong Liu, Renke Zhou, Erik P Sulman, et al.
Advanced Therapeutics|March 12, 2021
Induction of Immune Response Against Metastatic Tumors via Vaccination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibody (MBTA)Rogelio Medina, Herui Wang, Veronika Caisová, et al.
Neuro-Oncology|December 15, 2015
MiR-138 exerts anti-glioma efficacy by targeting immune checkpointsJun Wei, Edjah K Nduom, Ling-Yuan Kong, et al.
Neuro-Oncology Advances|March 5, 2025
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History StudyKaitlynn Slattery, McKenzie C Kauss, Dhaivat Raval, et al.
The Oncologist|February 17, 2021
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable ChordomaPeter Joseph DeMaria, Marijo Bilusic, Deric M Park, et al.
Pageof 46